NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Correlation
The correlation between NTR and BMY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NTR vs. BMY - Performance Comparison
Key characteristics
NTR:
0.33
BMY:
0.57
NTR:
0.69
BMY:
1.09
NTR:
1.08
BMY:
1.14
NTR:
0.15
BMY:
0.35
NTR:
0.57
BMY:
1.45
NTR:
15.27%
BMY:
11.60%
NTR:
26.79%
BMY:
29.21%
NTR:
-58.18%
BMY:
-70.62%
NTR:
-49.58%
BMY:
-25.45%
Fundamentals
NTR:
$25.88B
BMY:
$111.57B
NTR:
$1.48
BMY:
-$4.41
NTR:
1.30
BMY:
1.21
NTR:
$25.66B
BMY:
$48.30B
NTR:
$7.56B
BMY:
$32.20B
NTR:
$4.38B
BMY:
$3.16B
Returns By Period
In the year-to-date period, NTR achieves a 17.21% return, which is significantly higher than BMY's -1.72% return.
NTR
17.21%
1.61%
12.45%
8.40%
8.11%
N/A
BMY
-1.72%
-2.33%
16.04%
15.78%
0.07%
2.23%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NTR vs. BMY — Risk-Adjusted Performance Rank
NTR
BMY
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 4.12%, less than BMY's 4.40% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 4.12% | 4.83% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.40% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -58.18%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Volatility
NTR vs. BMY - Volatility Comparison
Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY) have volatilities of 9.08% and 8.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities